Reinsurance Gr Analyst Ratings
Analysts Offer Insights on Industrial Goods Companies: Evolv Technologies Holdings (EVLV), Plug Power (PLUG) and NVent Electric (NVT)
Analysts Offer Insights on Healthcare Companies: EyePoint Pharmaceuticals (EYPT), Sarepta Therapeutics (SRPT) and Intra-Cellular Therapies (ITCI)
Buy Rating Affirmed for Sarepta Therapeutics Amid Positive Revenue Outlook and Strong Pipeline Potential
Sarepta Therapeutics Price Target Cut to $181.00/Share From $182.00 by RBC Capital
Citigroup Maintains Neutral on Sarepta Therapeutics, Lowers Price Target to $160
TopBuild Analyst Ratings
Evercore Upgrades Sarepta to Outperform, but Lowers Price Target
Sarepta Therapeutics Price Target Cut to $179.00/Share From $185.00 by Evercore ISI Group
Oppenheimer Sticks to Their Buy Rating for Sarepta Therapeutics (SRPT)
Loop Capital Markets Remains a Buy on TopBuild (BLD)
Sarepta Therapeutics (SRPT) Gets a Buy From Piper Sandler
Buy Rating Affirmed for Sarepta Therapeutics Amidst Strong Growth Prospects and Pipeline Developments
Sarepta Therapeutics Analyst Ratings
NVent Electric Analyst Ratings
TopBuild Price Target Cut to $489.00/Share From $555.00 by Evercore ISI Group
Carvana Analyst Ratings
Truist Securities Maintains Hold on TopBuild, Lowers Price Target to $395
Analysts Conflicted on These Industrial Goods Names: Transdigm Group (TDG), NVent Electric (NVT) and ATI (ATI)
TopBuild (BLD) Receives a Rating Update From a Top Analyst